English | 繁體

Search in the results

UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
Sanggenon G, a Diels-Alder Adduct Screened from Mori Cortex, Attenuated Irinotecan-induced Late-onset Diarrhea in Mice via a Dual Inhibition Mechanism Conference paper
YAN RU, Wang, Panpan, Chen, Zhiqiang, Wu, Rongrong, Jia, Yifei. Sanggenon G, a Diels-Alder Adduct Screened from Mori Cortex, Attenuated Irinotecan-induced Late-onset Diarrhea in Mice via a Dual Inhibition Mechanism[C], 2023.
Authors:  YAN RU;  Wang, Panpan;  Chen, Zhiqiang;  Wu, Rongrong;  Jia, Yifei
Favorite |  | Submit date：2024/08/31
Sanggenon g, a Screened From , Attenuated In Mice Via a Dual Inhibition Mechanism  Diels-alder Adduct  Mori Cortex  Gus Inhibitor  Irinotecan-induced Diarrhea  Oatp2b1 Inhibition  Dual Inhibition  
An Isoquinolinium Dual Inhibitor of Cholinesterases and Amyloid β Aggregation Mitigates Neuropathological Changes in a Triple-Transgenic Mouse Model of Alzheimer's Disease Journal article
Ju,Yaojun, Chakravarty,Harapriya, Tam,Kin Yip. An Isoquinolinium Dual Inhibitor of Cholinesterases and Amyloid β Aggregation Mitigates Neuropathological Changes in a Triple-Transgenic Mouse Model of Alzheimer's Disease[J]. ACS Chemical Neuroscience, 2020, 11(20), 3346-3357.
Authors:  Ju,Yaojun;  Chakravarty,Harapriya;  Tam,Kin Yip
Favorite | TC[WOS]:6 TC[Scopus]:6  IF:4.1/4.3 | Submit date：2021/03/04
Alzheimer's Disease  Amyloid Beta  Cholinesterase  Dual Inhibition  
9R, the cholinesterase and amyloid beta aggregation dual inhibitor, as a multifunctional agent to improve cognitive deficit and neuropathology in the triple-transgenic Alzheimer's disease mouse model Journal article
Ju,Yaojun, Tam,Kin Yip. 9R, the cholinesterase and amyloid beta aggregation dual inhibitor, as a multifunctional agent to improve cognitive deficit and neuropathology in the triple-transgenic Alzheimer's disease mouse model[J]. Neuropharmacology, 2020, 181, 108354.
Authors:  Ju,Yaojun;  Tam,Kin Yip
Favorite | TC[WOS]:9 TC[Scopus]:9  IF:4.6/4.5 | Submit date：2021/03/04
Cholinesterase  Amyloid Beta  Dual Inhibition  Multifunction  Alzheimer's Disease  
A novel isoquinolinium dual inhibitor of cholinesterases and amyloid beta aggregation mitigates neuropathological changes in a triple-transgenic mouse model of Alzheimer’s disease Journal article
Ju, Y., Chakravarty, H., Tam, K. Y.. A novel isoquinolinium dual inhibitor of cholinesterases and amyloid beta aggregation mitigates neuropathological changes in a triple-transgenic mouse model of Alzheimer’s disease[J]. ACS Chemical Neuroscience, 2020, 3346-3357.
Authors:  Ju, Y.;  Chakravarty, H.;  Tam, K. Y.
Favorite | TC[WOS]:6 TC[Scopus]:6  IF:4.1/4.3 | Submit date：2022/07/27
Cholinesterase  Amyloid Beta  Dual Inhibition  Alzheimer’s Disease